About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Physical Activity in Hidradenitis Suppurativa (HS) | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT06015438

Physical Activity in Hidradenitis Suppurativa (HS)

The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.

Lead sponsor: University of Miami•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Hadar V Lev-Tov, MD

CONTACT

3052431953 hlevtov@med.miami.edu

Sponsors

Lead Sponsor

University of Miami

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults 18 years old to 80 years old
•Have diagnosis of HS confirmed by a dermatologist
•Able to provide informed consent
•For the extended portion of the study: Classified as having moderate-to-severe HS as per the IHS-4 criteria

Exclusion Criteria

•Individuals who are not yet adults
•Women known to be pregnant
•Prisoners
•Subjects, who in the opinion of the PI, cannot comply with the study procedures

Related studies

RECRUITINGPhase 3

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT06958211 · Hidradenitis Suppurativa

RECRUITINGPhase 3

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

NCT06921850 · Hidradenitis Suppurativa

RECRUITINGPhase 3

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182 · Hidradenitis Suppurativa

Myriad™ Augmented Soft Tissue Reconstruction Registry

NCT05243966 · Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, and more

RECRUITINGPhase 2

A Study With CIT-013 in HS Patients

NCT06993233 · Hidradenitis Suppurativa (HS)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 22, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment50

Start dateJun 2023

Last updatedSep 22, 2025

Condition

Hidradenitis Suppurativa

Locations shown

University of Miami

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 22, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions